TP53 and cancer: Although the potential mechanisms of the HK2 deregulation in cancer cells has not yet been fully elucidated, c-Myc, as well as HIF-1α and p53 have been proved to be involved in HK2 and HK2-mediated glycolysis demodulation [39,40,41].